A miRNA signature associated with human metastatic medullary thyroid carcinoma
Libero Santarpia(Humanitas University), Robert F. Gagel(The University of Texas MD Anderson Cancer Center)
Cited by 82
Related Papers
Activity of XL184 (Cabozantinib), an Oral Tyrosine Kinase Inhibitor, in Patients With Medullary Thyroid Cancer
|Journal of Clinical Oncology|2011|551
Vandetanib for the Treatment of Patients With Locally Advanced or Metastatic Hereditary Medullary Thyroid Cancer
|Journal of Clinical Oncology|2010|517
The Clinical Outcome of Prospective Screening for Multiple Endocrine Neoplasia Type 2A
|New England Journal of Medicine|1988|330
Plasma microRNA 210 levels correlate with sensitivity to trastuzumab and tumor presence in breast cancer patients
|Cancer|2011|291
Natural History of Familial Medullary Thyroid Carcinoma
|New England Journal of Medicine|1978|189